One Stop Shop for All Your Market Research Reports

Global Oral Vaccines Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality. According to our (Global Info Research) latest study, the global Oral Vaccines market size was valued at USD 2545.6 million in 2022 and is forecast to a readjusted size of USD 3375.9 million by 2029 with a CAGR of 4.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. The classification of oral vaccines includes rotavirus vaccine, cholera vaccine, oral polio vaccine and other types, and the sales proportion of polio vaccine is about 94%. Middle East and Africa is the largest consumption place, with a consumption market share nearly 54%. Following Middle East and Africa, Asia-Pacific is the second largest consumption place with the consumption market share of 31%. Market competition is intense. Merck, GSK and Sanofi, etc. are the leaders of the industry, with about 78% market shares. This report is a detailed and comprehensive analysis for global Oral Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided. Key Features: Global Oral Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029 Global Oral Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029 Global Oral Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029 Global Oral Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023 The Primary Objectives in This Report Are: To determine the size of the total market opportunity of global and key countries To assess the growth potential for Oral Vaccines To forecast future growth in each product and end-use market To assess competitive factors affecting the marketplace This report profiles key players in the global Oral Vaccines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, GSK, Sanofi, Lanzhou Institute and Serum Institute, etc. This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence. Market Segmentation Oral Vaccines market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets. Market segment by Type Rotavirus Vaccine Cholera Vaccine Oral Polio Vaccine Market segment by Application Public Private Major players covered Merck GSK Sanofi Lanzhou Institute Serum Institute Valneva Shanghai United Cell Bibcol PaxVax Vabiotech Tiantan Biological EuBiologics Panacea Biotec Ltd Bio-Med Halfkin Bio-Pharmaceuticals Market segment by region, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe) Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia) South America (Brazil, Argentina, Colombia, and Rest of South America) Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa) The content of the study subjects, includes a total of 15 chapters: Chapter 1, to describe Oral Vaccines product scope, market overview, market estimation caveats and base year. Chapter 2, to profile the top manufacturers of Oral Vaccines, with price, sales, revenue and global market share of Oral Vaccines from 2018 to 2023. Chapter 3, the Oral Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4, the Oral Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029. Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029. Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Oral Vaccines market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029. Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War. Chapter 13, the key raw materials and key suppliers, and industry chain of Oral Vaccines. Chapter 14 and 15, to describe Oral Vaccines sales channel, distributors, customers, research findings and conclusion.
1 Market Overview 1.1 Product Overview and Scope of Oral Vaccines 1.2 Market Estimation Caveats and Base Year 1.3 Market Analysis by Type 1.3.1 Overview: Global Oral Vaccines Consumption Value by Type: 2018 Versus 2022 Versus 2029 1.3.2 Rotavirus Vaccine 1.3.3 Cholera Vaccine 1.3.4 Oral Polio Vaccine 1.4 Market Analysis by Application 1.4.1 O
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 3480
Multi User US $5220
Corporate User US $6960
About this Report
Report ID 153738
Category
  • Pharmaceuticals and Healthcare
Published on 28-Mar
Number of Pages 114
Publisher Name Global Info Research
Editor Rating
★★★★★
★★★★★
(45)